Published in Blood on March 12, 2009
Telomere diseases. N Engl J Med (2009) 5.68
Ribosomopathies: human disorders of ribosome dysfunction. Blood (2010) 4.43
The telomere syndromes. Nat Rev Genet (2012) 4.01
The association of telomere length and cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev (2011) 3.29
Malignancies and survival patterns in the National Cancer Institute inherited bone marrow failure syndromes cohort study. Br J Haematol (2010) 3.09
TERC polymorphisms are associated both with susceptibility to colorectal cancer and with longer telomeres. Gut (2011) 2.75
A platform for rapid exploration of aging and diseases in a naturally short-lived vertebrate. Cell (2015) 2.65
Association of leukocyte telomere length with breast cancer risk: nested case-control findings from the Shanghai Women's Health Study. Am J Epidemiol (2013) 2.34
Germline mutations of regulator of telomere elongation helicase 1, RTEL1, in Dyskeratosis congenita. Hum Genet (2013) 2.10
Short telomeres are sufficient to cause the degenerative defects associated with aging. Am J Hum Genet (2009) 1.86
The genetics and clinical manifestations of telomere biology disorders. Genet Med (2010) 1.83
Somatic mutations identify a subgroup of aplastic anemia patients who progress to myelodysplastic syndrome. Blood (2014) 1.82
Telomere length measurement-caveats and a critical assessment of the available technologies and tools. Mutat Res (2011) 1.79
Telomere length is associated with disease severity and declines with age in dyskeratosis congenita. Haematologica (2011) 1.71
Incidence of neoplasia in Diamond Blackfan anemia: a report from the Diamond Blackfan Anemia Registry. Blood (2012) 1.69
rRNA pseudouridylation defects affect ribosomal ligand binding and translational fidelity from yeast to human cells. Mol Cell (2011) 1.61
Telomeres and age-related disease: how telomere biology informs clinical paradigms. J Clin Invest (2013) 1.58
Syndrome complex of bone marrow failure and pulmonary fibrosis predicts germline defects in telomerase. Blood (2011) 1.57
A spectrum of severe familial liver disorders associate with telomerase mutations. PLoS One (2009) 1.57
The genetics of dyskeratosis congenita. Cancer Genet (2011) 1.50
Deregulation of oncogene-induced senescence and p53 translational control in X-linked dyskeratosis congenita. EMBO J (2010) 1.47
Telomeres and disease. EMBO J (2009) 1.41
Frequency and natural history of inherited bone marrow failure syndromes: the Israeli Inherited Bone Marrow Failure Registry. Haematologica (2010) 1.36
Cancer in Noonan, Costello, cardiofaciocutaneous and LEOPARD syndromes. Am J Med Genet C Semin Med Genet (2011) 1.36
Familial myelodysplastic syndromes: a review of the literature. Haematologica (2011) 1.36
Dyskeratosis congenita. FEBS Lett (2010) 1.36
Dyskeratosis congenita as a disorder of telomere maintenance. Mutat Res (2011) 1.35
Ancestral mutation in telomerase causes defects in repeat addition processivity and manifests as familial pulmonary fibrosis. PLoS Genet (2011) 1.29
Spectrum and risk of neoplasia in Werner syndrome: a systematic review. PLoS One (2013) 1.23
How high are carrier frequencies of rare recessive syndromes? Contemporary estimates for Fanconi Anemia in the United States and Israel. Am J Med Genet A (2011) 1.23
Short telomeres result in chromosomal instability in hematopoietic cells and precede malignant evolution in human aplastic anemia. Leukemia (2011) 1.21
The evolving challenge of therapy-related myeloid neoplasms. Best Pract Res Clin Haematol (2013) 1.19
Stable long-term risk of leukaemia in patients with severe congenital neutropenia maintained on G-CSF therapy. Br J Haematol (2010) 1.17
Differences in disease severity but similar telomere lengths in genetic subgroups of patients with telomerase and shelterin mutations. PLoS One (2011) 1.16
Association of leukocyte telomere length with colorectal cancer risk: nested case-control findings from the Shanghai Women's Health Study. Cancer Epidemiol Biomarkers Prev (2012) 1.14
Lung transplantation for pulmonary fibrosis in dyskeratosis congenita: Case Report and systematic literature review. BMC Blood Disord (2011) 1.12
Small nucleolar RNAs in cancer. Biochim Biophys Acta (2012) 1.11
Short telomeres: from dyskeratosis congenita to sporadic aplastic anemia and malignancy. Transl Res (2013) 1.08
Outcomes of allogeneic hematopoietic cell transplantation in patients with dyskeratosis congenita. Biol Blood Marrow Transplant (2013) 1.07
Genomic characterization of the inherited bone marrow failure syndromes. Semin Hematol (2013) 1.07
Poly(A)-specific ribonuclease (PARN) mediates 3'-end maturation of the telomerase RNA component. Nat Genet (2015) 1.06
Marrow failure: a window into ribosome biology. Blood (2014) 1.06
The long and short of telomeres and cancer association studies. J Natl Cancer Inst (2013) 1.04
Many disease-associated variants of hTERT retain high telomerase enzymatic activity. Nucleic Acids Res (2013) 1.04
Understanding telomere diseases through analysis of patient-derived iPS cells. Curr Opin Genet Dev (2013) 1.03
Unraveling the pathogenesis of Hoyeraal-Hreidarsson syndrome, a complex telomere biology disorder. Br J Haematol (2015) 1.01
The impact of category, cytopathology and cytogenetics on development and progression of clonal and malignant myeloid transformation in inherited bone marrow failure syndromes. Haematologica (2015) 1.01
The gastrointestinal manifestations of telomere-mediated disease. Aging Cell (2013) 1.00
Immunologic aspects of hypoplastic myelodysplastic syndrome. Semin Oncol (2011) 0.98
Genetic predisposition to myelodysplastic syndrome and acute myeloid leukemia in children and young adults. Leuk Lymphoma (2015) 0.98
Molecular basis of telomere dysfunction in human genetic diseases. Nat Struct Mol Biol (2015) 0.97
Leukocyte telomere length, breast cancer risk in the offspring: the relations with father's age at birth. Mech Ageing Dev (2011) 0.94
The short and long telomere syndromes: paired paradigms for molecular medicine. Curr Opin Genet Dev (2015) 0.93
Zebrafish models for dyskeratosis congenita reveal critical roles of p53 activation contributing to hematopoietic defects through RNA processing. PLoS One (2012) 0.92
Dyskerin is required for tumor cell growth through mechanisms that are independent of its role in telomerase and only partially related to its function in precursor rRNA processing. Mol Carcinog (2010) 0.92
Telomere dynamics in mice and humans. Semin Hematol (2013) 0.92
The molecular genetics of the telomere biology disorders. RNA Biol (2015) 0.91
Telomere biology and translational research. Transl Res (2013) 0.90
Recognizing familial myeloid leukemia in adults. Ther Adv Hematol (2013) 0.90
Genetic predisposition syndromes: when should they be considered in the work-up of MDS? Best Pract Res Clin Haematol (2014) 0.89
Telomere dysfunction in human diseases: the long and short of it! Int J Clin Exp Pathol (2009) 0.89
Role of ribosomal protein mutations in tumor development (Review). Int J Oncol (2016) 0.88
Telomere-regulating genes and the telomere interactome in familial cancers. Mol Cancer Res (2014) 0.87
Genetic Variations in Telomere Maintenance, with Implications on Tissue Renewal Capacity and Chronic Disease Pathologies. Curr Pharmacogenomics Person Med (2010) 0.87
Compound heterozygous CORO1A mutations in siblings with a mucocutaneous-immunodeficiency syndrome of epidermodysplasia verruciformis-HPV, molluscum contagiosum and granulomatous tuberculoid leprosy. J Clin Immunol (2014) 0.86
Evaluation of Patients and Families With Concern for Predispositions to Hematologic Malignancies Within the Hereditary Hematologic Malignancy Clinic (HHMC). Clin Lymphoma Myeloma Leuk (2016) 0.86
hTERT promoter polymorphism, -1327C>T, is associated with the risk of epithelial cancer. Springerplus (2013) 0.84
Hereditary Predispositions to Myelodysplastic Syndrome. Int J Mol Sci (2016) 0.84
The accumulation and not the specific activity of telomerase ribonucleoprotein determines telomere maintenance deficiency in X-linked dyskeratosis congenita. Hum Mol Genet (2011) 0.83
Small RNAs with big implications: new insights into H/ACA snoRNA function and their role in human disease. Wiley Interdiscip Rev RNA (2014) 0.83
Epidemiology of childhood acute myeloid leukemia. Pediatr Blood Cancer (2013) 0.83
A homozygous telomerase T-motif variant resulting in markedly reduced repeat addition processivity in siblings with Hoyeraal Hreidarsson syndrome. Blood (2013) 0.83
The prognostic value of p53 mutation in pediatric marrow hypoplasia. Diagn Pathol (2011) 0.82
A case of dyskeratosis congenita with primary amenorrhea and adenocarcinoma of stomach. Indian J Dermatol (2011) 0.82
TERT Polymorphism rs2853669 Influences on Lung Cancer Risk in the Korean Population. J Korean Med Sci (2015) 0.81
Longer telomeres are associated with cancer risk in MMR-proficient hereditary non-polyposis colorectal cancer. PLoS One (2014) 0.81
Neuropsychiatric conditions among patients with dyskeratosis congenita: a link with telomere biology? Psychosomatics (2012) 0.81
Myeloid neoplasms with germline DDX41 mutation. Int J Hematol (2017) 0.79
Dyskeratosis congenita: a report of two cases. Case Rep Dent (2013) 0.79
Expression of the genetic suppressor element 24.2 (GSE24.2) decreases DNA damage and oxidative stress in X-linked dyskeratosis congenita cells. PLoS One (2014) 0.78
The Sub-Cellular Localization of WRAP53 Has Prognostic Impact in Breast Cancer. PLoS One (2015) 0.78
Radiation Sensitivity and Radiation Necrosis in the Short Telomere Syndromes. Int J Radiat Oncol Biol Phys (2015) 0.78
A Common Cancer Risk-Associated Allele in the hTERT Locus Encodes a Dominant Negative Inhibitor of Telomerase. PLoS Genet (2015) 0.77
Liver failure due to hepatic angiosarcoma in an adolescent with dyskeratosis congenita. J Pediatr Hematol Oncol (2014) 0.77
Neonatal manifestations of inherited bone marrow failure syndromes. Semin Fetal Neonatal Med (2015) 0.77
The challenging world of cytopenias: distinguishing myelodysplastic syndromes from other disorders of marrow failure. Oncologist (2014) 0.77
Telomere length reprogramming in embryos and stem cells. Biomed Res Int (2014) 0.76
A Reduced-Intensity Conditioning Regimen for Patients with Dyskeratosis Congenita Undergoing Hematopoietic Stem Cell Transplantation. Biol Blood Marrow Transplant (2016) 0.76
Telomere dynamics in induced pluripotent stem cells: Potentials for human disease modeling. World J Stem Cells (2011) 0.76
Neutrophil functions in patients with inherited bone marrow failure syndromes. Pediatr Blood Cancer (2010) 0.76
Multiple Mechanisms Contribute to the Cell Growth Defects Imparted by Human Telomerase Insertion in Fingers Domain Mutations Associated with Premature Aging Diseases. J Biol Chem (2016) 0.75
Loss of Drosophila pseudouridine synthase triggers apoptosis-induced proliferation and promotes cell-nonautonomous EMT. Cell Death Dis (2015) 0.75
Telomere Length Recovery: A Strong Predictor of Overall Survival in Acute Promyelocytic Leukemia. Acta Haematol (2016) 0.75
Transplantation for congenital bone marrow failure syndromes. Bone Marrow Res (2010) 0.75
Convergence of The Nobel Fields of Telomere Biology and DNA Repair. Photochem Photobiol (2016) 0.75
Cancer & inherited bone marrow failure states. Blood (2009) 0.75
Hoyeraal-Hreidarsson Syndrome due to PARN Mutations: Fourteen Years of Follow-Up. Pediatr Neurol (2015) 0.75
Critical role of the POT1 OB domain in maintaining genomic stability. Oncogene (2016) 0.75
Telomeres in aging and disease: lessons from zebrafish. Dis Model Mech (2016) 0.75
The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita. Nature (2001) 7.95
TINF2, a component of the shelterin telomere protection complex, is mutated in dyskeratosis congenita. Am J Hum Genet (2008) 4.12
Cancer incidence in persons with Fanconi anemia. Blood (2002) 4.05
Dyskeratosis congenita in all its forms. Br J Haematol (2000) 3.89
Very short telomere length by flow fluorescence in situ hybridization identifies patients with dyskeratosis congenita. Blood (2007) 3.86
Cancer in Fanconi anemia, 1927-2001. Cancer (2003) 3.31
Mutations in dyskeratosis congenita: their impact on telomere length and the diversity of clinical presentation. Blood (2005) 3.30
TINF2 mutations result in very short telomeres: analysis of a large cohort of patients with dyskeratosis congenita and related bone marrow failure syndromes. Blood (2008) 3.02
The incidence of leukemia and mortality from sepsis in patients with severe congenital neutropenia receiving long-term G-CSF therapy. Blood (2006) 2.82
Cancer risks in Fanconi anemia: findings from the German Fanconi Anemia Registry. Haematologica (2008) 2.72
Dyskeratosis congenita. Hematol Oncol Clin North Am (2009) 2.45
Hazard function estimation using B-splines. Biometrics (1995) 2.06
Diagnosis, genetics, and management of inherited bone marrow failure syndromes. Hematology Am Soc Hematol Educ Program (2007) 2.01
Risk of head and neck squamous cell cancer and death in patients with Fanconi anemia who did and did not receive transplants. Blood (2004) 1.97
Unrelated donor bone marrow transplantation for the treatment of Fanconi anemia. Blood (2006) 1.82
The role of telomere biology in bone marrow failure and other disorders. Mech Ageing Dev (2007) 1.56
Unusual complications after bone marrow transplantation for dyskeratosis congenita. Br J Haematol (1998) 1.47
Dyskeratosis congenita. Semin Hematol (2006) 1.34
Association of immune abnormalities with telomere shortening in autosomal-dominant dyskeratosis congenita. Blood (2004) 1.33
Dyskeratosis congenita fibroblasts are abnormal and have unbalanced chromosomal rearrangements. Blood (1992) 1.30
Prenatal and postnatal diagnosis and carrier detection of Fanconi anemia by a cytogenetic method. Pediatrics (1981) 1.26
Skewed X-chromosome inactivation in female carriers of dyskeratosis congenita. Am J Hum Genet (1997) 1.25
Individualized risks of first adverse events in patients with Fanconi anemia. Blood (2004) 1.09
Mutations in the reverse transcriptase component of telomerase (TERT) in patients with bone marrow failure. Blood Cells Mol Dis (2006) 1.09
Dyskeratosis congenita associated with three malignancies. J Eur Acad Dermatol Venereol (2003) 1.06
Allogeneic marrow transplantation for aplastic anaemia associated with dyskeratosis congenita. Br J Haematol (1996) 1.01
Fatal diffuse capillaritis after hematopoietic stem-cell transplantation for dyskeratosis congenita despite low-intensity conditioning regimen. Bone Marrow Transplant (2005) 1.01
Splenic peliosis and rupture in patients with dyskeratosis congenita on androgens and granulocyte colony-stimulating factor. Br J Haematol (2007) 1.00
"Stem cell" origin of the hematopoietic defect in dyskeratosis congenita. Blood (1992) 0.99
DYSKERATOSIS CONGENITA. FIRST REPORT OF ITS OCCURRENCE IN A FEMALE AND A REVIEW OF THE LITERATURE. Arch Dermatol (1963) 0.97
Oral carcinoma in a young man: a case of dyskeratosis congenita. J Eur Acad Dermatol Venereol (2000) 0.91
THE ASSOCIATION OF DYSKERATOSIS CONGENITA AND FANCONI'S ANAEMIA. Med J Aust (1965) 0.90
Dyskeratosis congenita. Report of a large kindred. Br J Dermatol (1981) 0.90
Tongue cancer as a complication of dyskeratosis congenita in a woman. Am J Otolaryngol (2000) 0.90
Unusual hypersensitivity to radiation therapy in a patient with dyskeratosis congenita syndrome. Oral Oncol (2004) 0.89
Case report: gastric carcinoma as a complication of dyskeratosis congenita in an adolescent boy. Dig Dis Sci (1996) 0.88
Dyskeratosis congenita. Br J Oral Surg (1971) 0.88
Dyskeratosis congenita: its connections with oral and maxillofacial surgery. Br J Oral Maxillofac Surg (2005) 0.88
Dyskeratosis congenita with pigmentation, dystrophia unguium, and leukoplakia oris; a follow-up report of two brothers. AMA Arch Derm (1958) 0.85
One novel and two recurrent missense DKC1 mutations in patients with dyskeratosis congenita (DKC). Genet Couns (2001) 0.85
Dyskeratosis congenita (Zinsser-Cole-Engman syndrome). An autopsy case presenting with rectal carcinoma, non-cirrhotic portal hypertension, and Pneumocystis carinii pneumonia. Virchows Arch A Pathol Anat Histopathol (1990) 0.85
Dyskeratosis congenita; relationship to poikiloderma atrophicans vasculare and to aplastic anemia of Fanconi. AMA Arch Derm (1957) 0.84
Dyskeratosis congenita with macular cutaneous amyloid deposits. Arch Dermatol (1984) 0.84
Identification of DKC1 gene mutations in Japanese patients with X-linked dyskeratosis congenita. Br J Haematol (2005) 0.84
[Zinsser-Engman-Cole syndrome with an extensive dyschromia of the skin]. Przegl Dermatol (1970) 0.83
Dyskeratosis congenita and associated interstitial lung disease: a case report. Acta Clin Belg (1998) 0.83
Oral squamous cell carcinoma in a case of dyskeratosis congenita. Ann Dent (1994) 0.83
[Leukoplakia, pigment changes and ungual dystrophy. Zinsser-Cole-Engman syndrome--so-called congenital dyskeratosis]. Med Welt (1966) 0.83
Delayed diagnosis of dyskeratosis congenita in a 40-year-old woman with multiple head and neck squamous cell carcinomas. Br J Dermatol (2007) 0.83
Dyskeratosis congenita. Pediatr Radiol (1997) 0.82
[Congenital dyskeratosis or Zinsser-Cole-Engman dyskeratosis. A probable female case]. Presse Med (1995) 0.82
Letter: Dyskeratosis congenita Zinsser-Cole-Engman form with abnormal karyotype. Dermatologica (1975) 0.81
[X-linked dyskeratosis congenita with aplastic anemia--genetic and hematologic studies]. Zhonghua Yi Xue Za Zhi (Taipei) (1989) 0.81
Dyskeratosis congenita in an adolescent girl with associated choanal atresia. Pediatr Dermatol (2005) 0.81
Dyskeratosis congenita. Haematologic, cytogenetic, and dermatologic studies. Scand J Haematol (1984) 0.81
Abnormal nails in a patient with severe anemia. Dyskeratosis congenita. Arch Dermatol (1997) 0.80
[A case report of dyskeratosis congenita with pancytopenia in special reference to hemopoietic stem cells]. Rinsho Ketsueki (1982) 0.80
[Dyskeratosis congenita (Zinsser-Engman-Cole)]. Przegl Dermatol (1975) 0.80
[Zinsser-Engman-Cole syndrome]. Hautarzt (1983) 0.80
[Zinsser-Cole-Engman syndrome. Congenital dyskeratosis]. Med Cutan Ibero Lat Am (1982) 0.80
Association of extensive brain calcifications, myelofibrosis, and retinopathy in a 12-year-old child. Pediatr Dev Pathol (2007) 0.79
Dyskeratosis congenita and nasopharyngeal atresia. J Laryngol Otol (1992) 0.79
[Zinsser-Engman-Cole syndrome (dyskeratosis congenita) in a 13-year-old boy]. Wiad Lek (1988) 0.79
Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol (2011) 12.10
Osteosarcoma incidence and survival rates from 1973 to 2004: data from the Surveillance, Epidemiology, and End Results Program. Cancer (2009) 6.00
A genome-wide association study of lung cancer identifies a region of chromosome 5p15 associated with risk for adenocarcinoma. Am J Hum Genet (2009) 5.62
Pathway analysis by adaptive combination of P-values. Genet Epidemiol (2009) 4.48
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nat Genet (2013) 4.35
TINF2, a component of the shelterin telomere protection complex, is mutated in dyskeratosis congenita. Am J Hum Genet (2008) 4.12
Very short telomere length by flow fluorescence in situ hybridization identifies patients with dyskeratosis congenita. Blood (2007) 3.86
Detectable clonal mosaicism and its relationship to aging and cancer. Nat Genet (2012) 3.69
The association of telomere length and cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev (2011) 3.29
Malignancies and survival patterns in the National Cancer Institute inherited bone marrow failure syndromes cohort study. Br J Haematol (2010) 3.09
Worldwide trends in incidence rates for oral cavity and oropharyngeal cancers. J Clin Oncol (2013) 3.00
Age-specific trends in incidence of noncardia gastric cancer in US adults. JAMA (2010) 2.78
PGA: power calculator for case-control genetic association analyses. BMC Genet (2008) 2.71
Age-related crossover in breast cancer incidence rates between black and white ethnic groups. J Natl Cancer Inst (2008) 2.64
Dietary fat and postmenopausal invasive breast cancer in the National Institutes of Health-AARP Diet and Health Study cohort. J Natl Cancer Inst (2007) 2.63
Underlying causes of the black-white racial disparity in breast cancer mortality: a population-based analysis. J Natl Cancer Inst (2009) 2.33
Competing risks analysis of correlated failure time data. Biometrics (2007) 2.31
The association between leukocyte telomere length and cigarette smoking, dietary and physical variables, and risk of prostate cancer. Aging Cell (2009) 2.22
Resampling-based multiple hypothesis testing procedures for genetic case-control association studies. Genet Epidemiol (2006) 2.21
Male breast cancer: a population-based comparison with female breast cancer. J Clin Oncol (2009) 2.20
Trends in U.S. pleural mesothelioma incidence rates following simian virus 40 contamination of early poliovirus vaccines. J Natl Cancer Inst (2003) 2.19
Prophylactic oophorectomy reduces breast cancer penetrance during prospective, long-term follow-up of BRCA1 mutation carriers. J Clin Oncol (2005) 2.11
Germline mutations of regulator of telomere elongation helicase 1, RTEL1, in Dyskeratosis congenita. Hum Genet (2013) 2.10
Clinical and molecular features associated with biallelic mutations in FANCD1/BRCA2. J Med Genet (2006) 2.10
Cancer incidence in Denmark following exposure to poliovirus vaccine contaminated with simian virus 40. J Natl Cancer Inst (2003) 2.07
Telomere shortening and loss of self-renewal in dyskeratosis congenita induced pluripotent stem cells. Nature (2011) 2.03
Disruption of telomerase trafficking by TCAB1 mutation causes dyskeratosis congenita. Genes Dev (2011) 1.98
Incidence of breast cancer in the United States: current and future trends. J Natl Cancer Inst (2011) 1.97
Breast cancer mortality trends in the United States according to estrogen receptor status and age at diagnosis. J Clin Oncol (2007) 1.97
International osteosarcoma incidence patterns in children and adolescents, middle ages and elderly persons. Int J Cancer (2009) 1.91
Natural history of autoimmune lymphoproliferative syndrome associated with FAS gene mutations. Blood (2014) 1.88
Effects of CCR5-Delta32 and CCR2-64I alleles on HIV-1 disease progression: the protection varies with duration of infection. AIDS (2003) 1.81
Gender is an age-specific effect modifier for papillary cancers of the thyroid gland. Cancer Epidemiol Biomarkers Prev (2009) 1.78
Variants in or near KITLG, BAK1, DMRT1, and TERT-CLPTM1L predispose to familial testicular germ cell tumour. J Med Genet (2011) 1.73
End-stage liver disease in persons with hemophilia and transfusion-associated infections. Blood (2002) 1.73
Telomere length is associated with disease severity and declines with age in dyskeratosis congenita. Haematologica (2011) 1.71
Divergent cancer pathways for early-onset and late-onset cutaneous malignant melanoma. Cancer (2009) 1.71
Incidence of neoplasia in Diamond Blackfan anemia: a report from the Diamond Blackfan Anemia Registry. Blood (2012) 1.69
Declining incidence of contralateral breast cancer in the United States from 1975 to 2006. J Clin Oncol (2011) 1.67
Cancer in Fanconi anemia. Blood (2003) 1.63
Telomere length in blood, buccal cells, and fibroblasts from patients with inherited bone marrow failure syndromes. Aging (Albany NY) (2010) 1.62
Commentary: meta-analysis of individual participants' data in genetic epidemiology. Am J Epidemiol (2002) 1.59
Effects of estrogen receptor expression and histopathology on annual hazard rates of death from breast cancer. Breast Cancer Res Treat (2006) 1.58
The association of telomere length and genetic variation in telomere biology genes. Hum Mutat (2010) 1.53
Pathway analysis of breast cancer genome-wide association study highlights three pathways and one canonical signaling cascade. Cancer Res (2010) 1.51
Telomere length in peripheral leukocyte DNA and gastric cancer risk. Cancer Epidemiol Biomarkers Prev (2009) 1.48
Ocular and orbital manifestations of the inherited bone marrow failure syndromes: Fanconi anemia and dyskeratosis congenita. Ophthalmology (2009) 1.47
All in the family: disclosure of "unwanted" information to an adolescent to benefit a relative. Am J Med Genet A (2008) 1.44
Epidemiologic evidence for a role of telomere dysfunction in cancer etiology. Mutat Res (2011) 1.37
Frequency and natural history of inherited bone marrow failure syndromes: the Israeli Inherited Bone Marrow Failure Registry. Haematologica (2010) 1.36
Cancer in Noonan, Costello, cardiofaciocutaneous and LEOPARD syndromes. Am J Med Genet C Semin Med Genet (2011) 1.36
Age-period-cohort models in cancer surveillance research: ready for prime time? Cancer Epidemiol Biomarkers Prev (2011) 1.36
Leukocyte telomere length in a population-based case-control study of ovarian cancer: a pilot study. Cancer Causes Control (2009) 1.32
Estimating age-specific breast cancer risks: a descriptive tool to identify age interactions. Cancer Causes Control (2007) 1.28
Correlates of spontaneous clearance of hepatitis C virus among people with hemophilia. Blood (2005) 1.28
Variants in the VCAM1 gene and risk for symptomatic stroke in sickle cell disease. Blood (2002) 1.27
Prostaglandin-endoperoxide synthase 2 (PTGS2) gene polymorphisms and risk of biliary tract cancer and gallstones: a population-based study in Shanghai, China. Carcinogenesis (2005) 1.23
Trimodal age-specific incidence patterns for Burkitt lymphoma in the United States, 1973-2005. Int J Cancer (2010) 1.23
A role for heterochromatin protein 1γ at human telomeres. Genes Dev (2011) 1.22
Dyskeratosis congenita: the first NIH clinical research workshop. Pediatr Blood Cancer (2009) 1.22
Updates on the biology and management of dyskeratosis congenita and related telomere biology disorders. Expert Rev Hematol (2013) 1.20
Etiologic heterogeneity for cervical carcinoma by histopathologic type, using comparative age-period-cohort models. Cancer Epidemiol Biomarkers Prev (2009) 1.18
Apolipoprotein E/C1 locus variants modify renal cell carcinoma risk. Cancer Res (2009) 1.18
Genome-wide association study of relative telomere length. PLoS One (2011) 1.16
Variants in inflammation genes and the risk of biliary tract cancers and stones: a population-based study in China. Cancer Res (2008) 1.14
Likelihood ratio test for detecting gene (G)-environment (E) interactions under an additive risk model exploiting G-E independence for case-control data. Am J Epidemiol (2012) 1.14
Intensive immunosuppression therapy for aplastic anemia associated with dyskeratosis congenita. Int J Hematol (2006) 1.13
Lung transplantation for pulmonary fibrosis in dyskeratosis congenita: Case Report and systematic literature review. BMC Blood Disord (2011) 1.12
LINE-1 methylation is inherited in familial testicular cancer kindreds. BMC Med Genet (2010) 1.11
Mutations in the reverse transcriptase component of telomerase (TERT) in patients with bone marrow failure. Blood Cells Mol Dis (2006) 1.09
Squamous cell carcinomas in patients with Fanconi anemia and dyskeratosis congenita: a search for human papillomavirus. Int J Cancer (2013) 1.08
The chromosome 2p21 region harbors a complex genetic architecture for association with risk for renal cell carcinoma. Hum Mol Genet (2011) 1.08
Telomere length and the risk of cutaneous malignant melanoma in melanoma-prone families with and without CDKN2A mutations. PLoS One (2013) 1.07
Outcomes of allogeneic hematopoietic cell transplantation in patients with dyskeratosis congenita. Biol Blood Marrow Transplant (2013) 1.07
Effects of CCR5-delta32 and CCR2-64I alleles on disease progression of perinatally HIV-1-infected children: an international meta-analysis. AIDS (2003) 1.07
Genomic characterization of the inherited bone marrow failure syndromes. Semin Hematol (2013) 1.07
Height at diagnosis and birth-weight as risk factors for osteosarcoma. Cancer Causes Control (2011) 1.07
A recessive founder mutation in regulator of telomere elongation helicase 1, RTEL1, underlies severe immunodeficiency and features of Hoyeraal Hreidarsson syndrome. PLoS Genet (2013) 1.05
Telomere biology in hematopoiesis and stem cell transplantation. Blood Rev (2011) 1.05
The long and short of telomeres and cancer association studies. J Natl Cancer Inst (2013) 1.04
Li-Fraumeni syndrome: report of a clinical research workshop and creation of a research consortium. Cancer Genet (2012) 1.04
Pleuropulmonary blastoma: a report on 350 central pathology-confirmed pleuropulmonary blastoma cases by the International Pleuropulmonary Blastoma Registry. Cancer (2014) 1.04
Reconstruction of the hepatitis C virus epidemic in the US hemophilia population, 1940-1990. Am J Epidemiol (2007) 1.03
Analysis of SNPs and haplotypes in vitamin D pathway genes and renal cancer risk. PLoS One (2009) 1.03
Divergent trends for gastric cancer incidence by anatomical subsite in US adults. Gut (2011) 1.02
HIV-associated Hodgkin lymphoma during the first months on combination antiretroviral therapy. Blood (2011) 1.02